Bridging With Chimeric Antigen Receptor T‐Cell Therapy or Chemotherapy to Allo‐ HSCT in B‐ ALL : A Comparison of Treatment Complications and Survival is a research paper published in European Journal of Haematology (2026). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Key Research and Development Program of China
Grant: 2023YFC2508905
National Key Research and Development Program of China
Grant: 2022YFA1103300
National Natural Science Foundation of China
Grant: 82470214
National Natural Science Foundation of China
Grant: 82270227
Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park
Grant: Z211100002921071
Major Program of the National Natural Science Foundation of China
Grant: 82293630
Beijing Research Ward Excellence Program
Grant: BRWEP2024W134080102
Peking University Medicine Fund for world's leading discipline or discipline cluster development
Grant: 71003Y3035
FWCI
0.00
Citation Percentile
0.1%
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals